My PCR
Create Account
Logo PCR

21 May 2026

Acute heart failureChronic heart failureTAVI

TAVI in heart failure is possible

Session comprising selected EuroPCR 2026 clinical cases submissions

Moderators: S. Toggweiler, A. Alcocer
Speakers: M. Yacoub, T. T.nguyen, R. Thonangi, E. Tseng, S. R. Justin, H. Alvarado Mora

Summary

This session demonstrates the feasibility of transcatheter aortic valve implantation (TAVI) in patients with heart failure through a series of challenging cases. It covers sequential management of hypertrophic obstructive cardiomyopathy with aortic stenosis, advanced heart failure interventions, staged approaches in cardiogenic shock, and complex percutaneous interventions in severe left ventricular dysfunction.

Presentations available when logged in:

  • Sequential transcatheter management of combined HOCM and aortic stenosis
  • A challenging case of advanced heart failure in a young patients
  • A staged approach to cardiogenic shock in low-flow aortic stenosis, coronary ischaemia with ITP
  • Planned CPB successfully supports concomitant TF - TAVR/PCI in patient with acute cardiogenic shock
  • Double trouble in the left ventricular outflow tract
  • Severe aortic valve stenosis with advanced left ventricular dysfunction: a challenging percutaneous intervention
Related Content
TAVI versus SAVR in aortic stenosis, is the debate still relevant in 2026? Structural and Valvular Interventions: EuroPCR 2026 highlights TAVI: LIVE Educational Case from Cleveland Clinic - London, UK
Recommended for you
Register for the PCR Fundamentals Course London 2026 Call for Submissions to GulfPCR-GIM and PCR Gulf Valves 2027 TAVI without routine PCI: PRO-TAVI randomized controlled trial